SPHINX31
SPHINX31 is a potent and selective inhibitor of serine/arginine-rich protein kinase 1 (SRPK1), with an IC50 of 5.9 nM. SPHINX31 inhibits phosphorylation of serine/arginine-rich splicing factor 1 (SRSF1). SPHINX31 is a potential topical therapeutic for neovascular eye disease[1].
| Trivial name | / |
| Catalog Number | CSN23673 |
| Alternative Name(s) | / |
| Research Area | / |
| Molecular Formula | C27H24F3N5O2 |
| CAS# | 1818389-84-2 |
| Purity | ≥99% |
| SMILES | O=C(C1=CC=C(C2=CC=NC=C2)O1)NC3=CC(C(F)(F)F)=CC=C3N4CCN(CC5=NC=CC=C5)CC4 |
| Size | 25mg |
| Supplier Page | https://www.csnpharm.com/products/sphinx31.html |